Founded Year

2012

Stage

Dead | Dead

Total Raised

$858.8M

About Olive

Olive provides healthcare revenue cycle management solutions. The company offers services for healthcare providers, including financial clearance, revenue capture, claim management, payment management, denial prevention, and analytics and reporting. Olive serves various sectors within the healthcare industry, such as physician and specialty practices, ambulatory surgery centers, clinical laboratories, and health systems. Olive was formerly known as CrossChx. It was founded in 2012 and is based in Columbus, Ohio. Olive ceased operations in October 2023.

Headquarters Location

99 East Main Street Suite 1750

Columbus, Ohio, 43215,

United States

800-501-3161

Loading...

Olive's Products & Differentiators

    Prior Authorization Suite

    Olive’s Prior Authorization Suite ensures you understand the comprehensive eligibility picture for each patient, by combining End-to-End Prior Authorization and Eligibility.

Loading...

Research containing Olive

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Olive in 9 CB Insights research briefs, most recently on May 29, 2024.

Expert Collections containing Olive

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Olive is included in 7 Expert Collections, including Robotic Process Automation.

R

Robotic Process Automation

322 items

RPA refers to the software-enabled automation of data-intensive tasks that are low-skill but highly sensitive operationally, including data entry, transaction processing, and compliance.

D

Digital Health 50

450 items

The most promising digital health startups transforming the healthcare industry

C

Conference Exhibitors

5,302 items

D

Digital Health

11,408 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

A

AI 100 (All Winners 2018-2025)

100 items

Winners of CB Insights' 5th annual AI 100, a list of the 100 most promising private AI companies in the world.

V

Value-Based Care & Population Health

193 items

Olive Patents

Olive has filed 53 patents.

The 3 most popular patent topics include:

  • social networking services
  • cubism
  • modern art
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/21/2020

4/1/2025

Videotelephony, Social networking services, Conservation and restoration, Teleconferencing, Machine learning

Grant

Application Date

6/21/2020

Grant Date

4/1/2025

Title

Related Topics

Videotelephony, Social networking services, Conservation and restoration, Teleconferencing, Machine learning

Status

Grant

Latest Olive News

Drive Capital’s second act –  how the Columbus venture firm found success after a split

Jul 5, 2025

1:25 PM PDT · July 5, 2025 The venture capital world has always had a hot-and-cold relationship with the Midwest. Investors rush in during boom times, then retreat to the coasts when markets turn sour. For Columbus, Ohio-based Drive Capital , this cycle of attention and disinterest played out against the backdrop of its own internal upheaval several years ago — a co-founder split that could have ended the firm but may have ultimately strengthened it. At a minimum, Drive achieved something newsworthy in today’s venture landscape this past May. The firm returned $500 million to investors in a single week, distributing nearly $140 million worth of Root Insurance shares within days of cashing out of Austin-based Thoughtful Automation and another undisclosed company. It could be seen as a gimmick, sure, but limited partners were undoubtedly pleased. “I’m unaware of any other venture firm having been able to achieve that kind of liquidity recently,” said Chris Olsen, Drive’s co-founder and now sole managing partner, who spoke to TechCrunch from the firm’s offices in Columbus’s Short North neighborhood. It’s a remarkable turnaround for a firm that faced existential questions just three years ago when Olsen and his co-founder Mark Kvamme — both former Sequoia Capital partners — went their separate ways. The split, which surprised the firm’s investors, saw Kvamme eventually launch the Ohio Fund, a broader investment vehicle focused on the state’s economic development that includes real estate, infrastructure, and manufacturing alongside technology investments. Drive’s recent success stems from what Olsen calls a deliberately contrarian strategy in an industry preoccupied with “unicorns” and “decacorns” — companies valued at $1 billion and $10 billion, respectively. “If you were to just read the newspapers or listen to coffee shops on Sand Hill Road, everyone always talks about the $50 billion or $100 billion outcomes,” Olsen said. “But the reality is, while those outcomes do happen, they’re really rare. In the last 20 years, there have only been 12 outcomes in America over $50 billion.” By contrast, he noted, there have been 127 IPOs at $3 billion or more, plus hundreds of M&A events at that level. “If you’re able to exit companies at $3 billion, then you’re able to do something that happens every single month,” he said. Techcrunch event Save $450 on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $450 on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA|July 15 That rationale underpinned the Thoughtful Automation exit, which Olsen described as “near fund-returning” despite being “below a billion dollars.” The AI healthcare automation company was sold to private equity firm New Mountain Capital, which combined it with two other companies to form Smarter Technologies. Drive owned “multiples” of the typical Silicon Valley ownership stake in the company, said Olsen, who added that Drive’s typical ownership stake is around 30% on average compared to a Valley firm’s 10% — often because it is the sole venture investor across numerous funding rounds. “We were the only venture firm who invested in that company,” Olsen said of Thoughtful Automation, which was previously backed by New Mountain, the PE firm. “About 20% of the companies in our portfolio today, we are the sole venture firm in those businesses.” Portfolio Wins and Losses Drive’s track record includes both big successes and also stumbles. The firm was an early investor in Duolingo, backing the language-learning platform when it was pre-revenue after Olsen and Kvamme met founder Luis von Ahn at a bar in Pittsburgh, where Duolingo is based. Today, Duolingo trades on NASDAQ with a market cap of nearly $18 billion. The firm also invested in Vast Data, a data storage platform last valued at $9 billion in late 2023 (and is reportedly fundraising right now), and Drive made money on the recent Root Insurance distribution despite that company’s rocky public market performance since its late 2020 IPO. But Drive also experienced the spectacular failure of Olive AI, a Columbus-based healthcare automation startup that raised over $900 million and was valued at $4 billion before eventually selling portions of its business in a fire sale. “You have to be able to produce returns in bad markets as well as good markets,” Olsen said. “When markets really get tested is when there’s not as much liquidity.” What sets Drive apart, Olsen argues, is its focus on companies building outside Silicon Valley’s hyper-competitive ecosystem. The firm now has employees in six cities — Columbus, Austin, Boulder, Chicago, Atlanta, and Toronto — and says it backs founders who would otherwise face a choice between building near their customers or their investors. It’s Drive’s secret sauce, he suggests. “Early-stage companies that are based outside of Silicon Valley have a higher bar. They have to be a better business to garner a venture investment from a venture firm in Silicon Valley,” Olsen said. “The same thing applies to us with companies in Silicon Valley. For us to invest in a company in Silicon Valley, it has a higher bar.” Much of the firm’s portfolio centers not on companies trying to come up with something entirely novel, but instead on those applying tech to traditional industries that coastal VCs might overlook. Drive has invested in an autonomous welding company, for example, and what Olsen calls “next-generation dental insurance” — sectors that arguably represent America’s $18 trillion economy beyond Silicon Valley’s tech darlings. Whether that focus — or Drive’s momentum — translates into a big new fund for Drive remains to be seen. The firm is currently managing assets that it raised when Kvamme was still on board, and according to Olsen, it has 30% left to invest of its current fund, a $1 billion vehicle announced in June 2022. Asked about cash-on-cash returns to date, Olsen said that with $2.2 billion in assets under management across all of Drive’s funds, all are “top quartile funds” with “north of 4x net on our most mature funds” and “continuing to grow from there.” In the meantime, Drive’s thesis about Columbus as a legitimate tech hub received further validation this week when Palmer Luckey, Peter Thiel, and other tech billionaires announced plans to launch Erebor , a crypto-focused bank headquartered in Columbus. “When we started Drive in 2012, people thought we were nuts,” Olsen said. “Now you’re seeing literally the people I think of as being the smartest minds in technology — whether it’s Elon Musk or Larry Ellison or Peter Thiel — moving out of Silicon Valley and opening massive presences in different cities.” Topics

Olive Frequently Asked Questions (FAQ)

  • When was Olive founded?

    Olive was founded in 2012.

  • Where is Olive's headquarters?

    Olive's headquarters is located at 99 East Main Street, Columbus.

  • What is Olive's latest funding round?

    Olive's latest funding round is Dead.

  • How much did Olive raise?

    Olive raised a total of $858.8M.

  • Who are the investors of Olive?

    Investors of Olive include Tiger Global Management, Vista Equity Partners, Base10 Partners, Drive Capital, General Catalyst and 16 more.

  • Who are Olive's competitors?

    Competitors of Olive include Illumicare, FastAuth, TachyHealth, Cohere Health, Rotera and 7 more.

  • What products does Olive offer?

    Olive's products include Prior Authorization Suite and 2 more.

Loading...

Compare Olive to Competitors

Rhyme Logo
Rhyme

Rhyme operates as a technology company focused on automating the prior authorization process within the healthcare sector. The company provides prior authorization services, a solution to eliminate the need for prior authorizations at the point of care, and a shared dashboard for visualization and collaboration between payers and providers. Rhyme primarily serves the healthcare industry, facilitating interactions between payers and providers to improve patient care. Rhyme was formerly known as PriorAuthNow. It was founded in 2016 and is based in New Albany, Ohio.

Notable Logo
Notable

Notable is an artificial intelligence (AI) platform that automates healthcare operations. The company offers solutions for patient engagement, workflow automation, and electronic health record (EHR) integration. Notable serves the healthcare sector with tools related to patient acquisition and retention. It was founded in 2017 and is based in San Mateo, California.

AKASA Logo
AKASA

AKASA provides generative AI (artificial intelligence) solutions for the healthcare revenue cycle, concentrating on financial processes within the healthcare sector. The company's offerings include automation and optimization of prior authorization, medical coding, claim status updates, and claim attachment processes, powered by generative AI trained on clinical and financial data. It serves hospitals and health systems, with a goal of improving operational efficiency and financial outcomes. AKASA was formerly known as Alpha Health. It was founded in 2018 and is based in San Francisco, California.

Cohere Health Logo
Cohere Health

Cohere Health serves as a clinical intelligence company that focuses on utilization management and prior authorization in the healthcare sector. The company provides solutions for the prior authorization process, which include intelligent prior authorization, compliance with healthcare regulations, and a platform for health plans to manage their utilization management operations. It was founded in 2019 and is based in Boston, Massachusetts.

Janus Logo
Janus

Janus specializes in optimizing healthcare revenue cycle management through data-driven solutions. The company offers a suite of tools that automate and enhance the efficiency of revenue cycle operations, such as claim processing and denial management, for healthcare providers. It caters to the healthcare industry. It was founded in 2020 and is based in Chicago, Illinois.

Epic Logo
Epic

Epic is a company focused on developing healthcare software within the health informatics sector. Their main offerings include software solutions that enable medical records and facilitate patient care, as well as tools for healthcare interoperability. Epic's products primarily serve the healthcare industry. Epic was formerly known as Human Services Computing, Inc.. It was founded in 1979 and is based in Verona, Wisconsin.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.